Home - Products - Metabolic Enzyme/Protease - Xanthine Oxidase (XAO) - Niraxostat

Niraxostat

CAS No. 206884-98-2

Niraxostat( Y 700 | Y-700 | Y700 )

Catalog No. M28003 CAS No. 206884-98-2

Niraxostat is one of the isocytosine derivatives as xanthine oxidase inhibitors.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	328	In Stock
5MG	300	In Stock
10MG	468	In Stock
25MG	749	In Stock
50MG	1042	In Stock
100MG	1386	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Niraxostat
Note

Research use only, not for human use.
Brief Description

Niraxostat is one of the isocytosine derivatives as xanthine oxidase inhibitors.
Description

Niraxostat is one of the isocytosine derivatives as xanthine oxidase inhibitors.
In Vitro

——
In Vivo

——
Synonyms

Y 700 | Y-700 | Y700
Pathway

Metabolic Enzyme/Protease
Target

Xanthine Oxidase (XAO)
Recptor

Ligand for E3 Ligase
Research Area

——
Indication

——

Chemical Information

CAS Number

206884-98-2
Formula Weight

299.33
Molecular Formula

C16H17N3O3
Purity

>98% (HPLC)
Solubility

——
SMILES

CC(C)(C)COc1ccc(cc1C#N)-n1cc(cn1)C(O)=O
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Andrew P. Crew, et al. Imide-based modulators of proteolysis and associated methods of use. US20160058872A1.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Xanthine oxidoreduct...

Xanthine oxidoreductase-IN-4 is an orally active xanthine oxidoreductase (XOR) inhibitor with an IC50 value of 29.3 nM, useful for studying hyperuricemia.
Xanthine oxidoreduct...

Xanthine oxidoreductase-IN-5 is an orally active inhibitor of xanthine oxidoreductase (XOR) with an IC50 of 55 nM. Xanthine oxidoreductase-IN-5 may be used in studies of acute hyperuricemia.
Tigulixostat

Tigulixostat (LC350189) is a novel xanthine oxidase inhibitor (XOI) that reduces uric acid production and may be used in studies of gout-related diseases.

Sign In Join Free